Aziz H, Güvener A, Akhtar S W, Hasan K Z
Department of Neurology, Jinnah Postgraduate Medical Centre, Karachi, Pakistan.
Epilepsia. 1997 Jun;38(6):716-22. doi: 10.1111/j.1528-1157.1997.tb01242.x.
To determine comparative prevalence rates, demographics, phenomenology, seizure classification, presumptive etiology, treatment status, and selected socioanthropological aspects of epilepsy in Pakistan and Turkey.
A population-based, cross-cultural comparative study of epilepsy was designed with identical protocols to be performed simultaneously in Pakistan and Turkey. The essential feature of the design was an unselected population, with reference to their previous medical contact, and use of standardized International Community-Based Epilepsy Research Group (ICBERG) protocols to assess cross-cultural differences.
In all, 24,130 persons in Pakistan and 11,497 persons in Turkey (both urban and rural, of all ages and both sexes) were studied. The crude prevalence rate of epilepsy was 9.98 in 1,000 in Pakistan and 7.0 in 1,000 in Turkey (14.8 in 1,000 in rural and 7.4 in 1,000 in urban areas of Pakistan; 8.8 in 1,000 in rural and 4.5 in 1,000 in urban areas of Turkey). In both countries, epilepsy was twice as prevalent in rural areas than in urban areas. Mean age of onset of epilepsy was 13.3 years in Pakistan and 12.9 years in Turkey. Overall frequency of seizure types was similar in both countries, with no urban/rural differences. The frequency distribution in Pakistan and Turkey, respectively, was as follows; generalized tonic-clonic, 80.5 and 65.4%; simple partial, 5 and 7.4%; complex partial, 5 and 12.3%; generalized absence, 0.8 and 4.9%; tonic and atonic, 5.8 and 3.7% each; and myoclonic, 5.8 and 1.2%. A putative cause for the epilepsy could be attributed in 38.4% of cases in Pakistan and 35.7% of cases in Turkey. Only 3% of patients in Pakistan, but 71% of patients in Turkey, believed that their illness was due to supernatural causes. The treatment status was very poor. In Pakistan, 27.5% of people with epilepsy in urban areas and 1.9% of people with epilepsy in rural areas were receiving antiepileptic drugs (AEDs) at the time of the survey. In, Turkey 30% of patients were receiving AEDs (marginally higher in rural areas).
The prevalence of epilepsy is slightly higher in Pakistan than in Turkey; some marginal differences in age and sex distribution, are not statistically significant. The results are comparable to those in Ecuador, where the same epidemiologic protocol was used.
确定巴基斯坦和土耳其癫痫的比较患病率、人口统计学特征、现象学、癫痫发作分类、推测病因、治疗状况以及选定的社会人类学方面。
设计了一项基于人群的癫痫跨文化比较研究,采用相同方案同时在巴基斯坦和土耳其进行。该设计的基本特征是未选定人群,参考他们以前的医疗接触情况,并使用标准化的国际社区癫痫研究组(ICBERG)方案来评估跨文化差异。
总共对巴基斯坦的24130人和土耳其的11497人(包括城市和农村地区、所有年龄段和两性)进行了研究。巴基斯坦癫痫的粗患病率为千分之9.98,土耳其为千分之7.0(巴基斯坦农村地区为千分之14.8,城市地区为千分之7.4;土耳其农村地区为千分之8.8,城市地区为千分之4.5)。在这两个国家,农村地区癫痫的患病率都是城市地区的两倍。巴基斯坦癫痫的平均发病年龄为13.3岁,土耳其为12.9岁。两国癫痫发作类型的总体频率相似,无城乡差异。巴基斯坦和土耳其的频率分布分别如下:全身强直阵挛发作,80.5%和65.4%;单纯部分性发作,5%和7.4%;复杂部分性发作,5%和12.3%;失神发作,0.8%和4.9%;强直发作和失张力发作,各为5.8%和3.7%;肌阵挛发作,5.8%和1.2%。巴基斯坦38.4%的病例和土耳其35.7%的病例可归因于癫痫的推测病因。巴基斯坦只有3%的患者,但土耳其71%的患者认为他们的疾病是由超自然原因引起的。治疗状况非常差。在巴基斯坦,调查时城市地区27.5%的癫痫患者和农村地区1.9%的癫痫患者正在接受抗癫痫药物(AEDs)治疗。在土耳其,30%的患者正在接受AEDs治疗(农村地区略高)。
巴基斯坦癫痫的患病率略高于土耳其;年龄和性别分布存在一些微小差异,但无统计学意义。结果与使用相同流行病学方案的厄瓜多尔的结果相当。